2024 / 01

Next Paper
DOI: 10.47183/mes.2024.004
Copyright: © 2024 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

ORIGINAL RESEARCH

Correlations between serum levels of histamine, diamine oxidase, substance P in patients with chronic urticaria

Mikryukova NV1, Kalinina NM1,2
About authors

1 Nikiforov's All-Russian Center for Emergency and Radiation Medicine, EMERCOM of Russia, Saint Petersburg, Russia

2 Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia

Correspondence should be addressed: Natalya V. Mikryukova
Optikov, 54, Saint Petersburg, 197345, Russia; ofni.vokuyrkim@aylatan

About paper

Funding: the study was supported by the Nikiforov's All-Russian Center for Emergency and Radiation Medicine, EMERCOM of Russia, within the framework of the research project “Clinical and laboratory diagnosis of chronic urticaria in adults”.

Author contribution: the authors declare compliance of their authorship with the international ICMJE criteria. Mikryukova NV — data acquisition and analysis, manuscript writing; Kalinina NM — editing, introduction of fundamental changes, final approval of the version of the article.

Compliance with ethical standards: the subjects submitted the informed consent to participation in the study approved by the Ethics Committee of the Nikiforov's All-Russian Center for Emergency and Radiation Medicine, EMERCOM of Russia (protocol № 6/21 dated 24 June 2021).

Received: 2023-12-02 Accepted: 2024-02-16 Published online: 2024-03-14
|
  1. McEwen BS. Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology. 2000; 22 (2): 108–24.
  2. Musazzi L, Tornese P, Sala N, Popoli M. What acute stress protocols can tell us about PTSD and stress-related neuropsychiatric disorders. Front Pharmacol. 2018; 12 (9): 758. DOI: 10.3389/fphar.2018.00758. PMID: 30050444.
  3. Malagelada JR. The brain-gut team. Dig Dis. 2020; 38 (4): 293–8. DOI: 10.1159/000505810. PMID: 32114574.
  4. Chen P, Zhang L, Feng Y, Liu YF, Si TL, Su Z, et al. Brain-gut axis and psychiatric disorders: A perspective from bibliometric and visual analysis. Front Immunol. 2022; 16 (13): 1047007. DOI: 10.3389/fimmu.2022.1047007. PMID: 36466907.
  5. Shapovalova NS. The role of the gut-brain axis in functional gastrointestinal disorders. Children's Medicine of the North-West. 2021; 9 (4): 33–50. Russian.
  6. Chen Y, Lyga J. Brain-skin connection: stress, inflammation and skin aging. Inflamm Allergy Drug Targets. 2014; 13 (3): 177–90. DOI: 10.2174/1871528113666140522104422. PMID: 24853682.
  7. Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015; 28: 203–9.
  8. Wong ML, Inserra A, Lewis MD, Mastronardi CA, Leong L, Choo J, et al. Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition. Mol Psychiatry. 2016; 21 (6): 797–805.
  9. Dejea CM, Fathi P, Craig JM, Boleij A, Taddese R, Geis AL, et al. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science. 2018; 359 (6375): 592–7.
  10. Blagonravova AS, Galova EA, Shirokova IYu, Galova DA. The gut-brain axis — clinical study results. Experimental and Clinical Gastroenterology. 2023; 6: 5–13. DOI: 10.31146/1682-8658-ecg-214-6-5-13. Russian.
  11. Brsikyan LA, Poluektova EA, Poluektov MG. The gut microbiome as a factor in the development of Parkinson's disease. Neurology, Neuropsychiatry, Psychosomatics. 2023; 15 (1): 90–6. DOI: 10.14412/2074-2711-2023-1-90-96. Russian.
  12. Matsuno K, Ueta H, Shu Z, Xue-Dong X, Sawanobori Y, Kitazawa Y, et al. The microstructure of secondary lymphoid organs that support immune cell trafficking. Arch Histol Cytol. 2010; 73: 1–21. DOI: 10.1679/aohc.73.1.
  13. Thye AY, Bah YR, Law JW, Tan LT, He YW, Wong SH, et al. Gut-Skin Axis: Unravelling the Connection between the Gut Microbiome and Psoriasis. Biomedicines. 2022; 10 (5): 1037. DOI: 10.3390/biomedicines10051037. PMID: 35625774.
  14. Sinha S, Lin G, Ferenczi K. The skin microbiome and the gut-skin axis. Clin Dermatol. 2021; 39 (5): 829–39. DOI: 10.1016.
  15. Wang X, Li Y, Wu L, Xiao S, Ji Y, Tan Y, et al. Dysregulation of the gut-brain-skin axis and key overlapping inflammatory and immune mechanisms of psoriasis and depression. Biomed Pharmacother. 2021; 137: 111065. DOI: 10.1016/j.biopha.2020.111065.
  16. Ferraretto A, Donetti E, García-Mena J, Pacheco-López G. Editorial: The gut-skin-brain axis in human health and disease. Front Nutr. 2023; 16 (10): 1155614. DOI: 10.3389/fnut.2023.1155614. PMID: 36875850.
  17. Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocrine reviews. 2000; 21 (5): 457–87.
  18. Marek-Jozefowicz L, Czajkowski R, Borkowska A, Nedoszytko B, Żmijewski MA, Cubała WJ, et al. Axis in psoriasis-psychological, psychiatric, hormonal, and dermatological aspects. Int J Mol Sci. 2022; 23 (2): 669. DOI: 10.3390/ijms23020669. PMID: 35054853.
  19. Andrzej TS, Michal AZ, Przemyslaw MP, Jerzy PS, Ralf P, How UV. Light touches the brain and endocrine system through skin, and why, endocrinology. 2018; 159 (5): 1992–2007. DOI: 10.1210/en.2017-03230.
  20. Remröd C, Lonne-Rahm S, Nordlind K. Study of substance P and its receptor neurokinin-1 in psoriasis and their relation to chronic stress and pruritus. Arch Dermatol Res. 2007; 299 (2): 85–91. DOI: 10.1007/s00403-007-0745-x.
  21. Asadi S, Alysandratos KD, Angelidou A, Miniati A, Sismanopoulos N, Vasiadi M, et al. Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells. J Invest Dermatol. 2012; 132 (2): 324–9. DOI: 10.1038/jid.2011.334.
  22. Mijouin L, Hillion M, Ramdani Y, Jaouen T, Duclairoir-Poc C, Follet-Gueye ML, et al. Effects of a skin neuropeptide (substance p) on cutaneous microflora. PLoS One. 2013; 8 (11): 78773.
  23. Danilicheva IV, Ilina NI, Luss LV, et al. Federal Clinical Recommendations. Urticaria. Russian Journal of Allergy. 2018; 15 (5): 47–62. Russian.
  24. Smolinska S, Jutel M, Crameri R, O’Mahony L. Histamine and gut mucosal immune regulation. Allergy. 2013; 69 (3): 273–81. DOI: 10.1111/all.12330.
  25. Yusuke H, Hiroshi N, Minoru M, Tsutomu C. Clinical significance of serum diamine oxidase activity in inflammatory bowel disease: Importance of evaluation of small intestinal permeability. Inflammatory Bowel Diseases. 2011; 17 (2): 23–5. DOI: 10.1002/ibd.21588.
  26. Xu Y, Yao R, Zhao W, et al. Spirocyclopiperazinium salt compound DXL-A-24 improves visceral sensation and gut microbiota in a rat model of irritable bowel syndrome. Heliyon. 2023; 9 (6): 16544. DOI: 10.1016/j.heliyon.2023.e16544.
  27. Raskov H, Burcharth J, Pommergaard HC, Rosenberg J.Irritable bowel syndrome, the microbiota and the gut-brain axis. Gut Microbes. 2016; 7 (5): 365–83. DOI: 10.1080/19490976.2016.1218585.
  28. McEwen BS. The untapped power of allostasis promoted by healthy lifestyles. World Psychiatry. 2020; 19 (1): 57–8. DOI: 10.1002/wps.20720. PMID: 31922670.